News

Investor's Business Daily on MSN23m

Eli Lilly Hikes UK Mounjaro Price By Up To 170% As Trump Pressure Mounts

Eli Lilly said Thursday it will hike the UK list price of its diabetes and weight-loss drug Mounjaro by up to 170%.

Is Novo Nordisk facing its “Nokia moment”? Stock tumbles to $50 from a year-high of $139 amid disruptive rivals and shifting market forces

Novo Nordisk’s stock has tumbled from record highs after slashing its 2025 outlook, as fierce competition, leadership changes ...
Pharmaceutical Technology54m

Eli Lilly seeks more GPCR weight loss drugs in $1.3bn research deal

Eli Lilly will pay up to $1.3bn for Superluminal Medicines to discover and progress small-molecule therapeutics for GPCR ...